1Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, 19104, USA.
The short prolactin receptor (PRLr-S) isoform acts as a dominant negative, inhibiting signaling and proliferation. Only intermediate prolactin receptor (PRLr-I) homodimers mediate ligand-induced signaling and cellular growth.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: